Pharmacodynamic modeling of thrombopoietin, platelet, and megakaryocyte dynamics in patients with acute myeloid leukemia undergoing dose intensive chemotherapy.

MLA

Bernstein SH, et al. “Pharmacodynamic Modeling of Thrombopoietin, Platelet, and Megakaryocyte Dynamics in Patients with Acute Myeloid Leukemia Undergoing Dose Intensive Chemotherapy.” Journal of Clinical Pharmacology, vol. 42, no. 5, May 2002, pp. 501–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=105822621&authtype=sso&custid=ns315887.

APA

Bernstein SH, Jusko WJ, Krzyzanski W, Nichol J, & Wetzler M. (2002). Pharmacodynamic modeling of thrombopoietin, platelet, and megakaryocyte dynamics in patients with acute myeloid leukemia undergoing dose intensive chemotherapy. Journal of Clinical Pharmacology, 42(5), 501–511.

Chicago

Bernstein SH, Jusko WJ, Krzyzanski W, Nichol J, and Wetzler M. 2002. “Pharmacodynamic Modeling of Thrombopoietin, Platelet, and Megakaryocyte Dynamics in Patients with Acute Myeloid Leukemia Undergoing Dose Intensive Chemotherapy.” Journal of Clinical Pharmacology 42 (5): 501–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=105822621&authtype=sso&custid=ns315887.